OncoSil Medical Limited (OSL.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.71 (-5.33%) as of
Key statistics
- Market cap
- 26.06M
- Forward P/E
- -0.04
- EPS (TTM)
- -0.5100
- Dividend yield
- 0.00%
- 52-week range
- 0.3700 – 1.6400
- Beta
- 1.31
- Revenue (TTM)
- 5.09M
- Profit margin
- -213.40%
- Volume
- 12.89k
About OncoSil Medical Limited
OncoSil Medical Limited, a medical device company, develops and commercializes localised radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company offers OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Macquarie Park, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.